After comprehensive analysis, we found that both MET and RIPK2 are related to the prognosis of pancreatic ductal adenocarcinoma and provided some associated clues for clinical application and basic experiment research. The gene discussed is RIPK2; the disease is pancreatic ductal adenocarcinoma.